A major international study has assessed key bacterial targets that could form the basis of a new maternal vaccine to protect ...

New research from Liverpool School of Tropical Medicine (LSTM) has shown gut and bloodstream infections are caused by the same bacteria, giving hope of better prevention and diagnosis of deadly ...

A genetic signature in newborns can predict neonatal sepsis before symptoms even start to show, according to a new study. The study, led by University of British Columbia and Simon Fraser University ...

Sepsis leads to life-threatening organ failure due to dysregulated host responses to infection and presents uniquely across age groups. Neonatal sepsis, affecting infants in their first 28 days, ...

Neonatal sepsis remains a critical challenge in neonatal care, representing one of the leading causes of morbidity and mortality, particularly in low‐ and middle‐income settings. Characterised by a ...

Among the 981,869 children, 0.8% were diagnosed with sepsis and less than 0.1% diagnosed with meningitis; overall, 1.2% of children developed epilepsy during the study period. Children with clinically ...

A pioneering study presented today at ESCMID Global 2025 has uncovered the potential of interleukin-6 (IL-6) as a powerful diagnostic biomarker for the early detection of sepsis in high-risk patient ...

University of Maryland School of Medicine (UMSOM) researchers at the Center for Vaccine Development and Global Health (CVD) have been awarded $3.96 million to develop a maternal vaccine that prevents ...

A new study into sepsis in neonatal babies has uncovered the secrets of the bacteria’s success in causing this life-threatening condition. Using genomic sequencing, they have found how certain strains ...

A historical cohort study of neonates in the UMass Newborn Nursery and Neonatal Intensive Care Unit born between 1999 and 2008 who had sepsis evaluations within the first 24 hours of life was ...